Evidence map›Paper›PMID 27941780›Full record

Trial reportBone marrow transplantation2017

Good responses but high TRM in adult patients after MSC therapy for GvHD.

U Salmenniemi, M Itälä-Remes, J Nystedt, M Putkonen, R Niittyvuopio, K Vettenranta, M Korhonen

Abstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Observational
  8. Current advancements in nanotechnology for stem cells.International journal of surgery (London, England) · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

U SalmenniemiDepartment of Clinical Hematology and Stem Cell Transplantation, Turku University Hospital and University of Turku, Turku, Finland.
M Itälä-RemesDepartment of Clinical Hematology and Stem Cell Transplantation, Turku University Hospital and University of Turku, Turku, Finland.
J NystedtAdvanced Cell Therapy Centre, Finnish Red Cross Blood Service, Helsinki, Finland.
M PutkonenDepartment of Clinical Hematology and Stem Cell Transplantation, Turku University Hospital and University of Turku, Turku, Finland.
R NiittyvuopioComprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki University Hospital, Helsinki, Finland.
K VettenrantaHelsinki University Children's Hospital and University of Helsinki, Helsinki, Finland.
M KorhonenAdvanced Cell Therapy Centre, Finnish Red Cross Blood Service, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAdolescentAdultAgedAllograftsChildChild, PreschoolDisease-Free SurvivalFemaleHumansMaleMiddle AgedProspective Studies

Identifiers

PMID27941780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.